Explore the vast range of titles available.

WOM is a powerful marketing mean that could be at least twice as powerful as traditional marketing communications in influencing sales The broad majority of definitions identify WOM as being the spread of positive information about an encounter that a customer had with a service or a product. According to research, sustainability concept extends to include aspects of the organizations' practices that are related to environmental, economic and socio-cultural features. Universities and other HE also need to create the vision of needed changes toward achieving sustainability, assign responsibilities and provide rewards to the members who are committed to a long-term transformation of the university and actively respond to society's changing needs. To achieve a sustainable competitive advantage, companies need to possess a number of internal and external antecedents that can be employed to shape the distinctive position of the company on the market. This research defines the most important problems which face private higher educational institutes in Egypt under the fierce competition in the field of higher education .It provides recommendations which might help them continue their mission.

Hematopoietic Stem Cell Transplantation (HSCT) is the only potentially curative treatment option for the hematologic complications that occur in patients with Fanconi anemia (FA). In this study, we present a retrospective multicenter analysis from the Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT) of matched related donor HSCT for FA in adolescents and adults transplanted between 1988 and 2015. Forty-five patients received HSCT with a median age at transplant of 18 years, the interquartile range (IQR) (15–23.5); 25 (55.6%) patients were females and 20 (44.4%) were males. Conditioning regimen was fludarabine-based in 29 (64.4%) patients, irradiation-based in five (11.1%) patients, and the remaining patients received other combinations. Indication for HSCT was bone marrow failure in 39 (86.7%) and myelodysplastic syndrome in six (13.3%) patients. Stem cell source was bone marrow in 22 (48.9%), peripheral blood in 20 (44.4%), umbilical cord blood in one (2.2%), and combination of bone marrow and cord blood in two (4.4%) patients. Twenty-seven (60%) patients engrafted and five (11.1%) had primary engraftment failure. The median time to neutrophil engraftment was 14 days (range 10–21 days); median time for platelet engraftment was 17 days (10–33 days). The probability of developing grade II–IV acute GVHD for all patients was 7.0% and chronic GVHD 36.6%. No new malignancies were reported. The OS probability was 53.6% (95% CI, 38.3–68.9%) with a median follow-up of 13 months (95% CI, 1–240). Our HLA-matched related HSCT results in AYA patients with FA compare favorably with other reported international registry data.